Do Hospital Doctors Screen for Diabetes?

Abstract

Background One in five hospitalized patients presents with previously undetected diabetes mellitus (DM). We assessed whether hospital doctors measure HbA₁c in hospitalized patients and act consequently.

Methods Data from patients hospitalized between January 2013 and December 2014 in a Swiss teaching hospital was collected. We assessed the frequency of HbA1c measurements and the number of newly detected prediabetes or DM. We also examined whether HbA1c values were associated with the antidiabetic drugs prescription and reporting of DM in the discharge letter.

Results Of the 2618 patients studied, 298 (11.4%) had HbA₁c measured, of whom 136 (45.6%) had no previous history of DM. Of the 136 patients without history of DM, 51 (37.5%) had prediabetic state and 23 (16.9%) had DM. Newly detected prediabetes or DM were reported in 5.8% (3/51) and 65.8% of cases (15/23), respectively. Only half of patients (11/23, 47.8%) with newly detected DM received antidiabetic drug treatment at discharge. Patients with newly detected DM (n=23) had a longer length of stay (median and interquartile range: 16 [9–25] versus 10 [8–16] days, p=0.028) compared to patients without DM, while no such differences were found regarding in-hospital mortality.

Conclusions Hospital doctors seldom prescribe HbA1c measurement in medical hospitalized patients. Prescription of HbA₁c measurement leads to a high detection rate (53%) of (pre)DM among patients unaware of their status, but management and reporting of these conditions at discharge could be further improved.

Key words

diabetes mellitus - pre-diabetes - HbA1c measurement - in-hospital screening

• References

• 1 Firmann M, Mayor V, Vidal PM. et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC cardiovascular disorders 2008; 8: 6 doi: 10.1186/1471-2261-8-6
• 2 Kaiser A, Vollenweider P, Waeber G. et al. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: The CoLaus study. Diabetic medicine: A journal of the British Diabetic Association 2012; 29: 190-197 doi:10.1111/j.1464-5491.2011.03422.x
• 3 Kahn R, Alperin P, Eddy D. et al. Age at initiation and frequency of screening to detect type 2 diabetes: A cost-effectiveness analysis. Lancet 2010; 375: 1365-1374 doi:10.1016/S0140-6736(09)62162-0
• 4 [Anonymous]. Standards of medical care in diabetes--2014. Diabetes care 2014; 37 (Suppl. 01) S14-S80 doi:10.2337/dc14-S014
• 5 Saudek CD, Herman WH, Sacks DB. et al. A new look at screening and diagnosing diabetes mellitus. The Journal of clinical endocrinology and metabolism 2008; 93: 2447-2453 doi:10.1210/jc.2007-2174
• 6 Mazurek JA, Hailpern SM, Goring T. et al Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. The Journal of clinical endocrinology and metabolism 2010; 95: 1344-1348 doi:10.1210/jc.2009-1151
• 7 Wexler DJ, Nathan DM, Grant RW. et al. Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. The Journal of clinical endocrinology and metabolism 2008; 93: 4238-4244 doi:10.1210/jc.2008-1090
• 8 Guariguata L, Whiting DR, Hambleton I. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice 2014; 103: 137-149 10.1016/j.diabres.2013.11.002
• 9 Kufeldt J, Kovarova M, Adolph M. et al. Prevalence and Distribution of Diabetes Mellitus in a Maximum Care Hospital: Urgent Need for HbA1c-Screening. Exp Clin Endocrinol Diabetes 2017;
• 10 Maesa JM, Fernandez-Riejos P, Mora CS. et al. Evaluation of Bio-Rad D-100 HbA1c analyzer against Tosoh G8 and Menarini HA-8180 V. Pract Lab Med 2016; 5: 57-64 doi:10.1016/j.plabm.2016.05.002
• 11 Vrca Botica M, Carkaxhiu L, Kern J. et al. How to improve opportunistic screening by using EMRs and other data. The prevalence of undetected diabetes mellitus in target population in Croatia. Public Health 2017; 145: 30-38 doi:10.1016/j.puhe.2016.12.008
• 12 Greiver M, Aliarzadeh B, Moineddin R. et al. Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: Prevalence and patient characteristics. BMC family practice 2011; 12: 91 doi:10.1186/1471-2296-12-91
• 13 Valentine NA, Alhawassi TM, Roberts GW. et al. Detecting undiagnosed diabetes using glycated haemoglobin: An automated screening test in hospitalised patients. The Medical journal of Australia 2011; 194: 160-164
• 14 Snir A, Dabin B, Hyun K. et al. Glycosylated haemoglobin assessment in diabetic patients with acute coronary syndromes. Internal medicine journal 2016; 46: 574-582 doi:10.1111/imj.13038
• 15 Strack B, DeShazo JP, Gennings C. et al. Impact of HbA1c measurement on hospital readmission rates: analysis of 70,000 clinical database patient records. BioMed research international 2014; 2014: 781670 doi:10.1155/2014/781670
• 16 Malcolm JC, Kocourek J, Keely E. et al. Implementation of a screening program to detect previously undiagnosed dysglycemia in hospitalized patients. Canadian journal of diabetes 2014; 38: 79-84 doi: 10.1016/j.jcjd.2014.02.005
• 17 Estoppey D, Paccaud F, Vollenweider P. et al. Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007. BMC Public Health 2011; 11: 114 doi: 10.1186/1471-2458-11-114
• 18 Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S. et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. International journal of circumpolar health 2007; 66: 101-112
• 19 Zellweger U, Bopp M, Holzer BM. et al. Prevalence of chronic medical conditions in Switzerland: Exploring estimates validity by comparing complementary data sources. BMC Public Health 2014; 14: 1157 doi: 10.1186/1471-2458-14-1157